Valneva SE (VALN) Profit After Tax (2021 - 2026)

Valneva SE (VALN) posted quarterly Profit After Tax of -$36.5 million for Q1 2026, down 447.41% year-on-year from $10.5 million in Q1 2025, and up 82.22% on a QoQ basis from -$205.3 million in Q4 2025.

Valneva SE (VALN) Profit After Tax (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Profit After Tax for 6 consecutive years, with -$36.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Profit After Tax fell 447.41% year-over-year to -$36.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$178.1 million (down 152.93% YoY) and the FY2025 annual result came in at -$131.1 million, down 840.64% from the prior year.
  • Profit After Tax grew to -$36.5 million in Q1 2026 per VALN's latest filing, from -$205.3 million in the prior quarter.
  • Over the last five years, Profit After Tax for VALN reached as high as $97.9 million in Q3 2025 and fell as low as -$224.8 million in Q2 2022.
  • A 5-year average of -$27.1 million and a median of -$28.4 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2025 — Profit After Tax surged 1031.04% — and 2026, when it slumped 447.41%.
  • Year by year, Profit After Tax stood at -$50.3 million in 2022, then increased by 27.25% to -$36.6 million in 2023, then dropped by 14.87% to -$42.0 million in 2024, then slumped by 388.29% to -$205.3 million in 2025, then soared by 82.22% to -$36.5 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$36.5 million, -$205.3 million, and $97.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -36.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -36.50 Mn
Dec 31, 2025 -205.26 Mn
Sep 30, 2025 97.85 Mn
Jun 30, 2025 -34.20 Mn
Mar 31, 2025 10.51 Mn
Dec 31, 2024 -42.04 Mn
Sep 30, 2024 -10.51 Mn
Jun 30, 2024 -28.37 Mn
Mar 31, 2024 67.04 Mn
Dec 31, 2023 -36.59 Mn
Sep 30, 2023 -118.71 Mn
Jun 30, 2023 19.25 Mn
Mar 31, 2023 20.63 Mn
Dec 31, 2022 -50.30 Mn
Sep 30, 2022 82.41 Mn
Jun 30, 2022 -224.78 Mn
Mar 31, 2022 29.63 Mn
Dec 31, 2021 -363.41 Mn
Sep 30, 2021 181.54 Mn
Jun 30, 2021 66.79 Mn